MicroRNA: A novel target of curcumin in cancer therapy

被引:197
作者
Mirzaei, Hamed [1 ]
Masoudifar, Aria [2 ]
Sahebkar, Amirhossein [3 ]
Zare, Naser [4 ]
Nahand, Javid Sadri [5 ]
Rashidi, Bahman [6 ]
Mehrabian, Emadodin [7 ]
Mohammadi, Mohsen [8 ,9 ]
Mirzaei, Hamid Reza [10 ]
Jaafari, Mahmoud Reza [11 ]
机构
[1] Mashhad Univ Med Sci, Sch Med, Dept Med Biotechnol, Mashhad, Iran
[2] ACECR, Royan Inst Biotechnol, Cell Sci Res Ctr, Dept Mol Biotechnol, Esfahan, Iran
[3] Mashhad Univ Med Sci, Biotechnol Res Ctr, Mashhad, Iran
[4] Isfahan Univ Med Sci, Sch Med, Esfahan, Iran
[5] Iran Univ Med Sci, Sch Med, Dept Virol, Tehran, Iran
[6] Isfahan Univ Med Sci, Sch Med, Dept Anat Sci & Mol Biol, Esfahan, Iran
[7] Shiraz Univ Med Sci, Sch Med, Shiraz, Iran
[8] Lorestan Univ Med Sci, Razi Herbal Med Res Ctr, Fac Pharm, Khorramabad, Iran
[9] Lorestan Univ Med Sci, Dept Pharmaceut Biotechnol, Fac Pharm, Khorramabad, Iran
[10] Univ Tehran Med Sci, Sch Med, Dept Immunol, Tehran 1417613151, Iran
[11] Mashhad Univ Med Sci, Sch Pharm, Nanotechnol Res Ctr, Mashhad 917751365, Iran
关键词
cancer; curcumin; exosome; microRNA; therapy; TO-MESENCHYMAL TRANSITION; CELL LUNG-CANCER; TRANSCRIPTION FACTOR SP1; MULTIDRUG-RESISTANCE; UP-REGULATION; CIRCULATING MICRORNAS; PROMOTES APOPTOSIS; SIGNALING PATHWAY; DRUG-SENSITIVITY; GASTRIC-CANCER;
D O I
10.1002/jcp.26055
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Curcumin is known as a natural dietary polyphenol which is extracted from Curcuma longa L. It has been shown that curcumin has a variety of pharmacological effects such as antioxidant, anti-cancer, anti-inflammatory, and anti-microbial activities. Anti-cancer effects of curcumin are due to targeting of a wide range of cellular and molecular pathways involved in cancer pathogenesis including NF-kB, MAPK, PTEN, P53, and microRNAs (miRNA) network. Multiple lines of evidence have indicated that curcumin exerts its therapeutic effects via regulating miRNA expression (e.g., miR-1, miR-7, miR-9, miR-34a, miR-181, miR-21, and miR-19) which could lead to the regulation of underlying cellular and molecular pathways involved in cancer pathogenesis. Exosomes are one of the important classes of biological vehicles which could be released from various types of cells such as cancer cells and stem cells and could change the behavior of recipient cells. It has been shown that treatment of cancer cells with different dose of curcumin leads to the release of exosomes containing curcumin. These exosomes could induce anti-cancer properties in recipient cells and reduce tumor growth. Hence, exosomes containing curcumin could be applied as powerful tools for cancer treatment. Here, we highlighted various miRNAs which could be affected by curcumin in various types of cancer. Moreover, we highlight exosomes containing curcumin as suitable therapeutic tools in cancer therapy. Curcumin is known as a natural dietary polyphenol which is extracted from Curcuma longa L. It has been shown that curcumin has a variety of pharmacological effects such as antioxidant, anti-cancer, anti-inflammatory, and anti-microbial activities. Anti-cancer effects of curcumin are due to targeting of a wide range of cellular and molecular pathways involved in cancer pathogenesis including NF-kB, MAPK, PTEN, P53, and microRNAs (miRNA) network. Multiple lines of evidence have indicated that curcumin exerts its therapeutic effects via regulating miRNA expression (e.g., miR-1, miR-7, miR-9, miR-34a, miR-181, miR-21, and miR-19) which could lead to the regulation of underlying cellular and molecular pathways involved in cancer pathogenesis. Exosomes are one of the important classes of biological vehicles which could be released from various types of cells such as cancer cells and stem cells and could change the behavior of recipient cells. It has been shown that treatment of cancer cells with different dose of curcumin leads to the release of exosomes containing curcumin. These exosomes could induce anti-cancer properties in recipient cells and reduce tumor growth.
引用
收藏
页码:3004 / 3015
页数:12
相关论文
共 50 条
  • [21] Telomerase: A Target for Therapeutic Effects of Curcumin in Cancer
    Forouzanfar, Fatemeh
    Majeed, Muhammed
    Jamialahmadi, Tannaz
    Sahebkar, Amirhossein
    [J]. REVIEWS ON NEW DRUG TARGETS IN AGE-RELATED DISORDERS, PT II, 2021, 1286 : 135 - 143
  • [22] PKIB, a Novel Target for Cancer Therapy
    Musket, Anna
    Moorman, Jonathan P.
    Zhang, Jinyu
    Jiang, Yong
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (09)
  • [23] Spectrum of microRNAs and their target genes in cancer: intervention in diagnosis and therapy
    Dayakar, Alti
    Shanmukha, Kumar D.
    Kalangi, Suresh K.
    [J]. MOLECULAR BIOLOGY REPORTS, 2022, 49 (07) : 6827 - 6846
  • [24] Macro-Role of MicroRNA in Gastric Cancer
    Link, Alexander
    Kupcinskas, Juozas
    Wex, Thomas
    Malfertheiner, Peter
    [J]. DIGESTIVE DISEASES, 2012, 30 (03) : 255 - 267
  • [25] PDGF-D Signaling: A Novel Target in Cancer Therapy
    Wang, Zhiwei
    Kong, Dejuan
    Li, Yiwei
    Sarkar, Fazlul H.
    [J]. CURRENT DRUG TARGETS, 2009, 10 (01) : 38 - 41
  • [26] Treating cancer with microRNA replacement therapy: A literature review
    Hosseinahli, Nayer
    Aghapour, Mahyar
    Duijf, Pascal H. G.
    Baradaran, Behzad
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (08) : 5574 - 5588
  • [27] Advancing cancer therapy: The role of MicroRNA in clinical applications
    Li, Jianing
    Zhang, Yongsheng
    Fu, Tong
    Xing, Guoli
    Tong, Ying
    [J]. PHARMACOLOGICAL RESEARCH, 2024, 206
  • [28] Safe and targeted anticancer therapy for ovarian cancer using a novel class of curcumin analogs
    Rath, Kellie S.
    McCann, Georgia A.
    Cohn, David E.
    Rivera, Brian K.
    Kuppusamy, Periannan
    Selvendiran, Karuppaiyah
    [J]. JOURNAL OF OVARIAN RESEARCH, 2013, 6
  • [29] MicroRNA as a Novel Biomarker in the Diagnosis of Head and Neck Cancer
    Kabzinski, Jacek
    Maczynska, Monika
    Majsterek, Ireneusz
    [J]. BIOMOLECULES, 2021, 11 (06)
  • [30] Novel Insights Into the Role of MicroRNA in Lung Cancer Resistance to Treatment and Targeted Therapy
    Gong, Zhaohui
    Yang, Jie
    Li, Jingqiu
    Yang, Lihua
    Le, Yanping
    Wang, Shaomin
    Lin, Hui-Kuan
    [J]. CURRENT CANCER DRUG TARGETS, 2014, 14 (03) : 241 - 258